Nutex Health Inc (NUTX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Nutex Health Inc stock (NUTX) is currently trading at $100.38. Nutex Health Inc PE ratio is 9.06. Nutex Health Inc PS ratio (Price-to-Sales) is 0.77. Analyst consensus price target for NUTX is $221.67. WallStSmart rates NUTX as Underperform.
- NUTX PE ratio analysis and historical PE chart
- NUTX PS ratio (Price-to-Sales) history and trend
- NUTX intrinsic value — DCF, Graham Number, EPV models
- NUTX stock price prediction 2025 2026 2027 2028 2029 2030
- NUTX fair value vs current price
- NUTX insider transactions and insider buying
- Is NUTX undervalued or overvalued?
- Nutex Health Inc financial analysis — revenue, earnings, cash flow
- NUTX Piotroski F-Score and Altman Z-Score
- NUTX analyst price target and Smart Rating
Nutex Health Inc
📊 No data available
Try selecting a different time range
NUTX Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Nutex Health Inc (NUTX)
NUTX trades 45% above its Graham fair value of $71.26, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Nutex Health Inc (NUTX) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in return on equity, operating margin, price/sales. Concerns around revenue growth and eps growth. Fundamentals are solid but monitor weak areas for improvement.
Nutex Health Inc (NUTX) Key Strengths (4)
Every $100 of shareholder equity generates $59 in profit
Keeps $98 of every $100 in revenue after operating costs
Paying less than $1 for every $1 of annual revenue
Trading at 1.89x book value, attractively priced
Supporting Valuation Data
Nutex Health Inc (NUTX) Areas to Watch (5)
Revenue declining -41.10%, a shrinking business
Earnings declining -86.20%, profits shrinking
Thin profit margins with limited profitability
Small-cap company with higher risk but more growth potential
Moderate institutional interest at 39.31%
Nutex Health Inc (NUTX) Detailed Analysis Report
Overall Assessment
This company scores 55/100 in our Smart Analysis, earning a C- grade. Out of 9 metrics analyzed, 4 register as strengths (avg 9.5/10) while 5 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Return on Equity, Operating Margin, Price/Sales. Valuation metrics including Price/Sales (0.77), Price/Book (1.89) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 58.90%, Operating Margin at 97.50%.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Profit Margin. Growth concerns include Revenue Growth at -41.10%, EPS Growth at -86.20%, which may limit upside. Profitability pressure is visible in Profit Margin at 8.09%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 58.90% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at -41.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Return on Equity, Operating Margin) and negatives (Revenue Growth, EPS Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
NUTX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
NUTX's Price-to-Sales ratio of 0.77x trades at a deep discount to its historical average of 2.78x (73th percentile). The current valuation is 100% below its historical high of 181.88x set in Nov 2019, and Infinity% above its historical low of 0x in Mar 2024.
Compare NUTX with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Nutex Health Inc (NUTX) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
Nutex Health Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 875M with 41% decline year-over-year. Profit margins are thin at 8.1%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
ROE of 58.9% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 69M in free cash flow and 70M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 41% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Margin expansion: can Nutex Health Inc push profit margins above 15% as the business scales?
Volatility is elevated with a beta of 2.00, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Nutex Health Inc.
Bottom Line
Nutex Health Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Nutex Health Inc(NUTX)
NASDAQ
HEALTHCARE
MEDICAL CARE FACILITIES
USA
Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas.